Skip to main content

Table 3 Summary of CUA of CKD patients undergoing kidney transplant included in the review

From: Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review

Study

Country

Year

Perspective

Discount rate (%)

Time horizon

Model structure

CUA of transplanting infectious kidneys (n = 03)

 Kadatz et al. [26]

Canada

2018

Health- care payer and Societal

1.5

10 years

Markov decision model

 Kiberd et al. [27]

Canada

1994

Not explicitly stated (Health- care payer costs identified)

5

20 years

Not explicitly stated (Markov decision model identified)

 Schweitzer et al. [34]

USA

2007

Societal perspective

3

20 years

Markov decision model

CUA of kidney allocation policies (n = 09)

 Axelrod et al. [21]

USA

2018

Health- care payer

3

10 years

Discreet Event Simulation

 Smith et al. [35]

USA

2015

Health- care payer

3

20 years

Markov decision model

 Mutinga et al. [31]

USA

2005

Not explicitly stated (Health- care payer costs identified)

5

20 years

Markov decision model

 Schnitzler et al. [33]

USA

2003

Health- care payer

5

20 years

Markov decision model

 Bavanandan et al. [23]

Malaysia

2015

Health- care payer

3

Life time

Not explicitly stated (Markov decision model identified)

 Snyder et al. [36]

USA

2010

Societal perspective

3

10 years

Markov decision model

 Cavallo et al. [24]

Italy

2014

Health- care payer

3.5

05 years

Markov decision model

 Barnieh et al. [22]

Canada

2013

Health- care payer

5

Life time

Markov decision model

 Matas et al. [29]

USA

2003

Societal perspective

5

20 years

Markov decision model

CUA of technology used in KT (n = 04)

 Nguyen et al. [32]

Australia

2015

Health- care payer

5

20 years

Markov decision model

 McLaughlin et al. [30]

Canada

2006

Health- care payer

5

25 years

Markov decision model

 Groen et al. [25]

Europe

2012

Health- care payer

4

10 years

Markov decision model

 Liem et al. [28]

Netherlands

2003

Societal perspective

3

Life time

Markov decision model

  1. HCV NAT Hepatitis C nucleic acid test, CDC IRDs Centers for Disease Control classified increased risk donors, KDPI Kidney Donor Profile Index, ECD expanded criteria donor, SD standard donor, LKT living kidney transplant, DKT deceased kidney transplant, DBD donation after brain death,DCD donation after cardiac death, CDC complement-dependent cytotoxicity